How I Choose Biologics
Clinical decision-making, occurring at the intersection of the ’art’ and the ’science’ of medicine, remains enigmatic and controversial.
Blogs
Annual Review of Rheumatology Advances - 2014
This retrospective highlights several of the most impactful publications, trends, research and news that occurred in 2014.
Rheumatology Pearls from Twitter - Really?
To many of my colleagues (admitted Luddites) the mere mention of Twitter results in the “omi-god 360” eye roll with an accompanying snide comment.
A Rheumatology State of Mind
In 2012, a Medscape survey of US physicians revealed rheumatology as the most satisfying of medical specialties. This came as a surprise to many as rheumatologists see themselves as the Rodney Dangerfields of medical specialists.
Letter to the Expert: Is there life after ONJ?
Patient on bisphosphonates for several years, later placed on denosumab. After her 2nd dose, she developed ONJ. Patient then placed on daily teriparatide with resolution of ONJ and now has a normal BMD. She is about to complete her 2nd year of PTH therapy. What should she be treated with after PTH?
The Nine Lives of Hydroxychloroquine
The hydroxychloroquine story begins in 1638 when the wife of the Viceroy of Peru, Countess Cinchona, acquired malaria while living in the New World.
Hot Stuff Part IV: Cardiovascular Outcomes and Vasculitis
The last in a four-part series from the CCF's Biologic Therapies Summit, we examine how to reduce CV risks in practice plus the current status of vasulitis management and the role biologics may play.
Hot Stuff Part III: Zoster and Biologics: Special Considerations
Part III covers talks on H. Zoster, biologics and SpA.
Top 5 Things Rheumatologists Should Know about Vaccines
Rheumatologists should have a working knowledge on what vaccinations their patients need. The top 5 things rheumatologists should know about vaccines are...
Hot Stuff Part II: Current Status and Recommendations on Vaccines and Biologics
Part II highlights from the Cleveland Clinic's Biologic Therapies Summit.
The Electronic Medical Record: the Good, the Bad and the Ugly
Many of us in academic centers, for better and worse, have had more and longer experience with EMRs than some of our colleagues in practice.
